The development of advanced radiotherapy technologies has, in turn, resulted in an increased complexity of operations. Also, a high level of accuracy is needed at every step of the process to achieve ...

Want to buy a good dividend stock and secure a great price in the process? Three stocks that are trading at attractive ...

Bristol-Myers Squibb (NYSE:BMY – Get Free Report) has been assigned a consensus rating of “Hold” from the nineteen brokerages that are covering the company, Marketbeat.com reports. Two research ...

The most recent trading session ended with Bristol Myers Squibb (BMY) standing at $59.21, reflecting a +0.03% shift from the previouse trading day's closing. The stock outpaced the S&P 500's daily ...

Trump also nominated Republican attorney Thomas March Bell to lead the Department of Health and Human Service’s Office of Inspector General. Calley Means, a chronic disease entrepreneur and ...

Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...

The SEC has rebuffed a Bristol-Myers Squibb Co. campaign against a shareholder proposal urging it to scrap its diversity, ...

Exelixis' Cabometyx gains FDA approval for advanced neuroendocrine tumors, while phase 3 data confirms sustained survival ...

View the full release here: "It's exciting to see the growing real-world evidence showing how AI-enhanced ECG analysis can ...

BMS says it is combining AI and machine learning with its researchers’ expertise in drug targets and mechanisms of action, to ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

This was the stock's second consecutive day of losses.